Trials / Completed
CompletedNCT04439383
Risk Stratification for Venous Thromboembolism in Hospitalized Medical Patients
Risk Stratification for Hospital-Acquired Venous Thromboembolism in Medical Patients: a Prospective Cohort Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,353 (actual)
- Sponsor
- Insel Gruppe AG, University Hospital Bern · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Hospital-acquired venous thromboembolism (HA-VTE) is one of the leading preventable causes of in-hospital mortality, but prevention of VTE in hospitalized medical patients remains challenging, as preventive measures such as pharmacological thromboprophylaxis (TPX) need to be tailored to individual thrombotic risk. The broad objective of this project is to improve VTE prevention strategies in hospitalized medical patients by prospectively examining VTE risk factors (including mobility) and comparing existing risk assessment models.
Conditions
- Venous Thromboembolism
- Venous Thromboses
- Pulmonary Embolism
- Deep Vein Thrombosis
- Embolism and Thrombosis
- Mobility Limitation
- Hospital Acquired Condition
Timeline
- Start date
- 2020-06-22
- Primary completion
- 2022-04-01
- Completion
- 2022-04-01
- First posted
- 2020-06-19
- Last updated
- 2022-04-05
Locations
3 sites across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT04439383. Inclusion in this directory is not an endorsement.